Cited by 147Pregnancy and Medication ImpactPharmacological Effects and Toxicity StudiesPrenatal Substance Exposure Effects

Acetaminophen Use During Pregnancy and Children’s Risk of Autism, ADHD, and Intellectual Disability

Open access
Ahlqvist, Viktor H., Sjöqvist, Hugo, Dalman, Christina, Karlsson, Håkan, Stephansson, Olof, Johansson, Stefan, Magnusson, Cecilia, Gardner, Renee M. +1 more·2024·JAMA

Abstract

Importance: Several studies suggest that acetaminophen (paracetamol) use during pregnancy may increase risk of neurodevelopmental disorders in children. If true, this would have substantial implications for management of pain and fever during pregnancy. Objective: To examine the associations of acetaminophen use during pregnancy with children’s risk of autism, attention-deficit/hyperactivity disorder (ADHD), and intellectual disability. Design, Setting, and Participants: This nationwide cohort study with sibling control analysis included a population-based sample of 2 480 797 children born in 1995 to 2019 in Sweden, with follow-up through December 31, 2021. Exposure: Use of acetaminophen during pregnancy prospectively recorded from antenatal and prescription records. Main Outcomes and Measures: Autism, ADHD, and intellectual disability based on International Classification of Diseases, Ninth Revision and International Classification of Diseases, Tenth Revision codes in health registers. Results: In total, 185 909 children (7.49%) were exposed to acetaminophen during pregnancy. Crude absolute risks at 10 years of age for those not exposed vs those exposed to acetaminophen were 1.33% vs 1.53% for autism, 2.46% vs 2.87% for ADHD, and 0.70% vs 0.82% for intellectual disability. In models without sibling control, ever-use vs no use of acetaminophen during pregnancy was associated with marginally increased risk of autism (hazard ratio [HR], 1.05 [95% CI, 1.02-1.08]; risk difference [RD] at 10 years of age, 0.09% [95% CI, −0.01% to 0.20%]), ADHD (HR, 1.07 [95% CI, 1.05-1.10]; RD, 0.21% [95% CI, 0.08%-0.34%]), and intellectual disability (HR, 1.05 [95% CI, 1.00-1.10]; RD, 0.04% [95% CI, −0.04% to 0.12%]). To address unobserved confounding, matched full sibling pairs were also analyzed. Sibling control analyses found no evidence that acetaminophen use during pregnancy was associated with autism (HR, 0.98 [95% CI, 0.93-1.04]; RD, 0.02% [95% CI, −0.14% to 0.18%]), ADHD (HR, 0.98 [95% CI, 0.94-1.02]; RD, −0.02% [95% CI, −0.21% to 0.15%]), or intellectual disability (HR, 1.01 [95% CI, 0.92-1.10]; RD, 0% [95% CI, −0.10% to 0.13%]). Similarly, there was no evidence of a dose-response pattern in sibling control analyses. For example, for autism, compared with no use of acetaminophen, persons with low (<25th percentile), medium (25th-75th percentile), and high (>75th percentile) mean daily acetaminophen use had HRs of 0.85, 0.96, and 0.88, respectively. Conclusions and Relevance: Acetaminophen use during pregnancy was not associated with children’s risk of autism, ADHD, or intellectual disability in sibling control analysis. This suggests that associations observed in other models may have been attributable to familial confounding.

Integrity signals

Registry

Crossref · 10.1001/jama.2024.3172

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

The text we found for this paper looks like another document, so its claims and self-check weren’t run. The registry and citation checks still apply.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The text we found for this paper looks like another document, so the self-check wasn’t run.

Cites

Flagged first, then by citations

Research works printed but not linked: 6

  1. [8]8. Werler MM, Mitchell AA, Hernandez-Diaz S, Honein MA. Use of over-the-counter medications during pregnancy. American journal of obstetrics and gynecology. 2005;193(3):771-777.
  2. [10]10. Goksör E, Thengilsdottir H, Alm B, Norvenius G, Wennergren G. Prenatal paracetamol exposure and risk of wheeze at preschool age. Acta Paediatrica. 2011;100(12):1567-1571.
  3. [13]13. Wolgast E, Lindh-Åstrand L, Lilliecreutz C. Women's perceptions of medication use during pregnancy and breastfeeding-A Swedish cross-sectional questionnaire study. Acta obstetricia et gynecologica Scandinavica. 2019;98(7):856-864.
  4. [15]15. Wolgast E, Josefsson A, Josefsson M, Lilliecreutz C, Reis M. Drug use in pregnant women-a pilot study of the coherence between reported use of drugs and presence of drugs in plasma. European journal of clinical pharmacology. 2018;74:535-539.
  5. [18]18. Sari NP, Jansen PW, Blanken LM, et al. Maternal age, autistic-like traits and mentalizing as predictors of child autistic-like traits in a population-based cohort. Molecular Autism. 2022;13(1):26.
  6. [19]19. Sjölander A, Frisell T, Kuja-Halkola R, Öberg S, Zetterqvist J. Carryover effects in sibling comparison designs. Epidemiology. 2016;27(6):852-858.

Cited by

Sorted by citations

Authors
Ahlqvist, V. H., Sjöqvist, H., Dalman, C., Karlsson, H., Stephansson, O., Johansson, S., Magnusson, C., Gardner, R. M., & Lee, B. K.
Affiliations
  • Karolinska Institutet (SE)
  • Karolinska University Hospital (SE)
  • Region Stockholm (SE)
Corresponding author
Lee, Brian K.
Venue
JAMA
Published
2024-04-09
Volume
331
Issue
14
Pages
1205
ISSN
  • 0002-9955 (ISSN-L)
  • 0098-7484
OpenAlex
W4394633195
Cited by
147
References
42
Citations by year
2026: 74 · 2025: 57 · 2024: 16
FWCI
60.89
Type
journal article
Language
en
Open access
Locations
  • JAMA (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institute of Neurological Disorders and Stroke (R01NS107607, R01NS131433)
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (P50HD111142)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmacological Effects and Toxicity Studies
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Substance Exposure Effects
Keywords
paracetamol, prenatal drug exposure, autism spectrum disorder, attention deficit hyperactivity disorder, intellectual disability, neurodevelopmental disorders, confounding, maternal medication use
MeSH terms
Acetaminophen, Attention Deficit Disorder with Hyperactivity, Autistic Disorder, Child, Female, Follow-Up Studies, Humans, Intellectual Disability, Pregnancy, Prenatal Exposure Delayed Effects, Sweden, Cohort Studies, Confounding Factors, Epidemiologic, Neurodevelopmental Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review